Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-02-26
1998-05-26
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 435 691, C07K 1447, C07K 1472, C12N 1512
Patent
active
057564485
ABSTRACT:
Purified DNA encoding a Constitutive Activator of Retinoid acid response (CAR) receptors and the recombinant proteins expressed from such DNA are disclosed. The recombinant receptor polypeptides are members of the nuclear hormone receptor super family and are used to identify CAR ligands and CAR receptor binding sites and are also used to produce therapeutics. Antibodies specific for CAR receptor polypeptides are also disclosed.
REFERENCES:
patent: 4870009 (1989-09-01), Evans et al.
patent: 4981784 (1991-01-01), Evans et al.
patent: 5071773 (1991-12-01), Evans et al.
patent: 5077211 (1991-12-01), Yarosh
patent: 5183736 (1993-02-01), Pfahl et al.
Evans, Science 240:889-895, 1988.
Gebert et al., Oncogne, vol. 6, 1991, pp. 1859-1868.
Fuller, P.J. (1991) FASEB J. 5:3092-99.
Bugge, T.H., et al. (1992) EMBO J. 11:1409-18.
Kumar, V., et al. (1987) Cell 51:941-51.
Baes Myriam I.
Moore David D.
Fitzgerald David L.
The General Hospital Corporation
LandOfFree
Constitute activator of retinoid (CAR) receptor polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Constitute activator of retinoid (CAR) receptor polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Constitute activator of retinoid (CAR) receptor polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1959994